Isomorphic inks deals with Eli Lilly and Novartis for drug discovery | TechCrunch
[ad_1] Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into
Read More
AlphaFold